PBHG Stock | News | Quote | Stock Forum | Monday, November 25,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 25, 2013 at 1:42 AM

$PBHG PBS Holding, Inc. PBHG Company Overview

PBS Holding, Inc. PBHG Current Price and Quotes
Last Price 0.052
Previous Close 0.06 Open 0.055
Daily Range 0.0649 - 0.045 52wk Range 0.45 - 0.0035
Volume 295,753 Dividend N/A
Average Vol (3m) 518,201 Yield N/A

PBHG Stock Message Board http://investorshangout.com/search?q=PBHG&...mp;yt1=Go!

Last Updated: Monday, November 25, 2013 01:42:42 AM

PBS Holding, Inc. PBHG

Company Updated Profile
Company Information

1322 Roundtable Drive
Dallas, TX 75007

Website: http://www.PBSHoldinginc.com
Phone: 214-418-6940
Email: info@pbsholding.com
Find us on:

PBS Holding, Inc. PBHG
PBS Holding Inc and its direct sales group;Starfest Direct, recently launched a Functional Beverages product line, "De Vie Sun", which is translated, "Healthy Life". The company is using its Direct sales Starfest Technology web portal to market and advertise sales opportunities in home based direct sales business. Removed UTC after talking to Edward Vakser, he sent an update form. Also changed phone number. 9/13/2011 KS.

PBS Holding, Inc. PBHG
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Deregistered a/o Aug 17, 2007
Audited Financials Unaudited
Latest Report Sep 30, 2013 Quarterly Report
CIK 0001077150
Fiscal Year End 12/30
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 8999 - Services, misc
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 1996
Employees 6 a/o Feb 01, 2011
Company Officers/Contacts

Edward Vakser Co-Founder
Clark Ortiz CEO
Company Directors

Edward Vakser Chairman
Company Notes

Formerly=Primary Business Systems, Inc. until 10-05
Formerly=ShareCom, Inc. until 3-03
Formerly=Anonymous Data Corp. until 8-01
Note=12-98 company is in the development stage, formed to develop equipment and related software to store & retrieve data of medical laboratory testing
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Brian F. Faulkner, A Professional Law Corporation
27127 Calle Arroyo
San Juan Capistrano, CA, 92675
United States

Investor Relations Firm
Not Available

PBS Holding, Inc. PBHG
PBHG Security Details

Share Structure

Market Value1 $5,227,049 a/o Nov 22, 2013
Shares Outstanding 86,972,536 a/o Jun 30, 2013
Float 21,117,766 a/o Jun 25, 2013
Authorized Shares 750,000,000 a/o Jun 30, 2013
Par Value 0.001
Shareholders

Shareholders of Record 97 a/o Dec 31, 2012
Security Notes

Capital Change=shs decreased by 1 for 2500 split. Pay date=11/12/2002.
Capital Change=shs decreased by 1 for 322 split. Pay date=08/03/2001.
Capital Change=shs decreased by 1 for 8 split Pay date=10/03/2005.
Capital Change=shs decreased by 1 for 400 split. Pay date=05/12/2011.
Short Selling Data

Short Interest 0 (-100%)
Sep 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Island Stock Transfer

PBS Holding, Inc. PBHG Financials
Period Ending Dec 31, 2012 Sep 30, 2012 Dec 31, 2011
Total Revenue 33 33 70
Cost of Revenue - - 38
Gross Profit 33 33 32
Operating Expenses

Research and Development - - -
Sales, General and Admin. 229 217 2,558
Non-Recurring Items - - -
Other - - -
Operating Income (196) (185) (2,526)
Income From Continuing Operations

Add'l Income/Expense Items - - 399
Earnings Before Interest and Tax (196) (185) (2,127)
Interest Expense - - -
Earnings Before Tax (196) (185) (2,127)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (196) (185) (2,127)
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (196) (185) (2,127)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (196) (185) (2,127)

PBS Holding, Inc. PBHG Recent News

PBHG PBS Holding, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PBHG&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PBHG/quote
Stock Chart http://www.otcmarkets.com/stock/PBHG/chart
Company Info http://www.otcmarkets.com/stock/PBHG/company-info
Recent News http://www.otcmarkets.com/stock/PBHG/news
Financials http://www.otcmarkets.com/stock/PBHG/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PBHG/filings
Short Sales http://www.otcmarkets.com/stock/PBHG/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PBHG/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PBHG/research
Summary http://finance.yahoo.com/q?s=PBHG
Historical Prices http://finance.yahoo.com/q/hp?s=PBHG+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PBHG
Basic Chart http://finance.yahoo.com/q/bc?s=PBHG+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PBHG+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PBHG+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PBHG+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PBHG+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PBHG+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PBHG+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PBHG+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PBHG+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PBHG+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PBHG
Balance Sheet http://finance.yahoo.com/q/bs?s=PBHG
Cash Flow http://finance.yahoo.com/q/cf?s=PBHG+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PBHG
Market Watch http://www.marketwatch.com/investing/stock/PBHG
Bloomberg http://www.bloomberg.com/quote/PBHG:US
Morningstar http://quotes.morningstar.com/stock/s?t=PBHG
Bussinessweek http://investing.businessweek.com/research/st...icker=PBHG
Barchart http://www.barchart.com/quotes/stocks/PBHG
OTC Short Report http://otcshortreport.com/index.php?index=PBHG
Investopedia http://www.investopedia.com/markets/stocks/PBHG/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...